Ligand Pharmaceuticals reported $6.65M in Interest Income for its fiscal quarter ending in March of 2026.





Interest Income Change Date
Arrowhead Research USD 16.87M 7.18M Mar/2026
Baxter International USD 12M 1000K Mar/2026
Eli Lilly USD 65M 25M Sep/2025
Enviri Corporation USD -1.05 0.89 Dec/2024
Gilead Sciences USD 95M 0 Mar/2026
GlaxoSmithKline GBP 22M 96M Mar/2026
Glaxosmithkline GBP 22M 4M Mar/2026
Heron Therapeutics USD 433K 277K Dec/2021
Insmed USD 765K 55K Sep/2024
Intrexon USD 319K 602K Jun/2024
Ionis Pharmaceuticals USD -0.66 0.29 Dec/2024
Karyopharm Therapeutics USD -0.15 0.11 Dec/2024
Ligand Pharmaceuticals USD 6.65M 262K Mar/2026
MacroGenics USD 1.55M 26K Mar/2026
Merck USD 35M 34M Mar/2026
Pacira USD 1.93M 365K Mar/2026
Pfizer USD -0.04 115M Jun/2026
Rigel Pharmaceuticals USD 0.7 0.76 Sep/2024
Veracyte USD 3.48M 4K Mar/2026